Anthony Hamlett
Alfred Health(AU)
Publications by Year
Research Areas
Multiple Sclerosis Research Studies, Chronic Lymphocytic Leukemia Research, Acute Lymphoblastic Leukemia research, Cancer-related gene regulation, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis(2010)988 cited
- → Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis(2011)243 cited
- → Safety and tolerability of cladribine tablets in multiple sclerosis: the CLARITY (CLAdRIbine Tablets treating multiple sclerosis orallY) study(2011)131 cited
- → Mixed Models for Assessing Correlation in the Presence of Replication(2003)102 cited
- → MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study(2012)61 cited
- → Cladribine tablets for relapsing–remitting multiple sclerosis: Efficacy across patient subgroups from the phase III CLARITY study(2011)34 cited
- → Results from a Phase II Study of Isatuximab As a Single Agent and in Combination with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma(2018)25 cited
- → Dose Spacing in Early Dose Response Clinical Trial Designs(2002)19 cited
- Issues and trends in pediatric growth hormone therapy--an update from the GHMonitor observational registry.(2008)
- Effects of cladribine tablets on peripheral lymphocyte subtypes implicated in multiple sclerosis immunopathogenesis: surface marker analysis for a subset of patients from the 96-week, phase III, double-blind, placebo-controlled CLARITY study(2009)